BIOCRYST PHARMACEUTICALS INC earnings per share and revenue

BO1 earnings per share for the last quarter are -0.16 EUR whereas the estimation was -0.19 EUR which accounts for 18.80% surprise. Company revenue for the same period amounts to 85.97 M EUR despite the estimated figure of 79.35 M EUR. Estimated earnings per share for the next quarter are -0.16 EUR, and revenue is expected to reach 91.51 M EUR. Also watch annual changes over time to get a bigger picture of BO1 earnings per share and revenue dynamics.